Sabra Health Care REIT, Inc. (SBRA) has a consensus analyst rating of Hold, based on 29 analysts covering the stock. Of those, 11 recommend buying, 16 recommend holding, and 2 recommend selling.
The analyst consensus price target for SBRA is $21.33, representing a +4.9% upside from the current price of $20.34. Price targets range from a low of $21.00 to a high of $22.00.
